The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial
News
ERA’s latest news, insightful articles, and valuable resources on renal medicine.
10 / 29 results found
February 18, 2025
ASN-ERA-ISN
July 03, 2024
ASN-ERA-ISN
April 23, 2024
February 20, 2024
Biomedical Alliance
January 16, 2024
EKHA